 |
Web Film
AstraZeneca Brazil: The CO2 Inhaler
This is an archived ad - to view, please register for Bestads PRO membership or log in if you're already PRO. Ads on Bestads are free to view for the first week they appear. Register for FREE to view new ads.
According to the World Health Organisation, air pollution kills millions of people every year. In fact, carbon dioxide exacerbates respiratory conditions in patients suffering from COPD and Asthma - often leading these patients to premature deaths. AstraZeneca Brazil along with McCann Health created an innovative way to bring awareness to this epidemic. They launched the CO2 Inhaler, marking the first time pollution has been used to help patients breathe better. This special edition inhaler is made from carbon dioxide converted into biodegradable plastic, in order to create the plastic device which houses the canister of medication. The CO2 Inhaler is a collaboration between AstraZeneca Brazil, McCann Health Sao Paulo and New York. Together, they worked with one of the world’s top 100 chemists - Cornell University’s, Geoffrey Coates, who has been leading research and development of CO2 converted into plastic for over a decade. In addition, the team worked with Novomer, a leading sustainable manufacturing company Coates co-founded that specialises in the polymerisation of carbon dioxide.
Senior Product Manager: Viviane Milício Related |
The Best Ad JobsRetrieving latest jobs
advertising news |
 |
